recurrent mucoepidermoid carcinoma of the oral cavity
Showing 1 - 25 of >10,000
Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous
Recruiting
- Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
- +50 more
- transoral robotic surgery
- quality of life assessment
-
Columbus, OhioOhio State University Medical Center
Oct 28, 2022
Oral Cavity Squamous Cell Carcinoma Trial in San Francisco (NisinZ® P, Surgery (non-interventional, standard of care))
Not yet recruiting
- Oral Cavity Squamous Cell Carcinoma
- NisinZ® P
- Surgery (non-interventional, standard of care)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 18, 2023
Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IVA
Withdrawn
- Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity
- +6 more
- hypofractionated radiation therapy
- +3 more
-
New Brunswick, New Jersey
- +1 more
Sep 27, 2022
Oral Cavity Squamous Cell Carcinoma Trial in Yichang (Sintilimab, Radiotherapy)
Recruiting
- Oral Cavity Squamous Cell Carcinoma
- Sintilimab
- Radiotherapy
-
Yichang, Hubei, ChinaDepartment of Medical Oncology, Central Hospital of Yichang City
Feb 18, 2023
Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8
Not yet recruiting
- Oral Cavity Squamous Cell Carcinoma
- +4 more
- Near Infrared Imaging
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 5, 2022
Squamous Cell Carcinoma of Oral Cavity, Pharynx Carcinoma, Larynx Carcinoma Trial in Gliwice (Chemotherapy
Recruiting
- Squamous Cell Carcinoma of Oral Cavity
- +3 more
- Chemotherapy (carboplatin+paclitaxel) with concomitant low dose ionizing radiotherapy
-
Gliwice, Silesia, PolandThe Maria Sklodowska-Curie National Research Institute of Oncolo
Aug 7, 2023
Oral Squamous Cell Carcinoma, Maxillo-facial Surgery, Biomarkers Trial in Amiens (saliva tube)
Recruiting
- Oral Squamous Cell Carcinoma
- +5 more
- saliva tube
-
Amiens, Picardie, FranceAmiens University Hospital
Mar 17, 2023
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,
Recruiting
- Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +24 more
- Carboplatin
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
May 18, 2022
Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication
Completed
- Caregiver
- +37 more
- Communication Intervention
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Dec 14, 2022
WORST PATTERN OF INVASION IN ORAL SQUAMOUS CELL CARCINOMA
Recruiting
- Oral Cancer
- +2 more
- Biopsy Specimens Histopathology
-
Rawalpindi, Punjab, PakistanArmed Forces Institute of Pathology
Jun 22, 2023
Squamous Cell Carcinoma of the Oral Cavity Trial in Rouen (Circulating tumor DNA detection)
Not yet recruiting
- Squamous Cell Carcinoma of the Oral Cavity
- Circulating tumor DNA detection
-
Rouen, France
- +1 more
Jun 29, 2023
Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Houston (drug, behavioral, radiation)
Not yet recruiting
- Squamous Cell Carcinoma
- Oral Cavity Squamous Cell Carcinoma
- Tiragolumab
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jan 27, 2023
Oral Cavity Squamous Cell Carcinoma Trial in Leuven (Durvalumab, Durvalumab + Tremelimumab)
Active, not recruiting
- Oral Cavity Squamous Cell Carcinoma
- Durvalumab
- Durvalumab + Tremelimumab
-
Leuven, BelgiumUZ Leuven
May 30, 2022
Stage I Oral Cavity Squamous Cell Carcinoma, Stage II Oral Cavity Squamous Cell Carcinoma Trial in Buffalo, Rochester (drug,
Terminated
- Stage I Oral Cavity Squamous Cell Carcinoma
- Stage II Oral Cavity Squamous Cell Carcinoma
- HPPH
- +4 more
-
Buffalo, New York
- +1 more
May 6, 2022
Head Neck Cancer Trial in San Diego (Medpulser electroporation with Bleomycin, Tumor surgical excision)
Terminated
- Head and Neck Cancer
- Medpulser electroporation with Bleomycin
- Tumor surgical excision
-
San Diego, CaliforniaInovio Biomedical Corporation
Mar 2, 2022
Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous
Recruiting
- Recurrent Head and Neck Squamous Cell Carcinoma
- +5 more
- Efineptakin alfa
-
San Francisco, CaliforniaUniversity of California San Francisco
Jul 7, 2022
Oral Squamous Cell Carcinoma Trial in Shanghai (Camrelizumab Plus Docetaxel and Cisplatin)
Recruiting
- Oral Squamous Cell Carcinoma
- Camrelizumab Plus Docetaxel and Cisplatin
-
Shanghai, Shanghai, ChinaShanghai Ninth People's Hospital affiliated to Shanghai Jiao Ton
Nov 9, 2022
Neoadjuvant Pembrolizumab in III-IVA Resectable Oral Squamous
Recruiting
- Oral Cavity Squamous Cell Carcinoma
-
Guangzhou, Guangdong, ChinaLiuxiqiang
Feb 1, 2023
Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Oral Cavity
Active, not recruiting
- Squamous Cell Carcinoma of the Oropharynx
- +7 more
-
Tampa, Florida
- +2 more
Dec 30, 2022
Head and Neck Carcinoma of Unknown Primary, Locally Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Laryngeal
Recruiting
- Head and Neck Carcinoma of Unknown Primary
- +5 more
- External Beam Radiation Therapy
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 1, 2022
Squamous Cell Carcinoma of Head and Neck Trial in Hangzhou (Toripalimab)
Recruiting
- Squamous Cell Carcinoma of Head and Neck
-
Hangzhou, Zhejiang, ChinaDepartment of Medical Onocology, First Affiliated Hospital of Zh
Oct 7, 2023
Alcohol-Related Carcinoma, Fanconi Anemia, Oral Cavity Carcinoma Trial in Minneapolis (Alcohol, Biospecimen Collection, Breath
Recruiting
- Alcohol-Related Carcinoma
- +2 more
- Alcohol
- +2 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Jul 25, 2023
Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Trial (Black Raspberry)
Not yet recruiting
- Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
- Black Raspberry
- (no location specified)
Oct 16, 2023
Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Squamous Cell Carcinoma of the Hypopharynx, Metastatic Squamous
Active, not recruiting
- Metastatic Head and Neck Squamous Cell Carcinoma
- +9 more
- Carboplatin
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 27, 2022
Head Neck Cancer Trial in Boston (Nivolumab, Ipilimumab, Standard of Care Surgery)
Active, not recruiting
- Head and Neck Cancer
- Nivolumab
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Feb 22, 2022